Hsbc Holdings PLC Innoviva, Inc. Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

A detailed history of Hsbc Holdings PLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 57,832 shares of INVA stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,832

Previous 39,806 45.28%

Holding current value

$1.12 Million

Previous $606,000 56.44%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$14.4 - $16.4 $259,574 - $295,626	18,026 Added 45.28%	57,832 $948,000
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $258,949 - $298,432	17,785 Added 80.76%	39,806 $606,000
Q4 2023 Feb 12, 2024	BUY	$12.32 - $16.27 $271,298 - $358,281	22,021 New	22,021 $353,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $135,546 - $158,290	11,487 New	11,487 $152,000
Q2 2022 Aug 11, 2022	SELL	$14.32 - $19.88 $23,255 - $32,285	-1,624 Reduced 11.0%	13,146 $194,000
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $227,310 - $299,092	14,770 New	14,770 $288,000
Q2 2021 Aug 13, 2021	SELL	$11.45 - $13.96 $143,823 - $175,351	-12,561 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $209,963 - $244,324	-18,984 Reduced 60.18%	12,561 $150,000
Q4 2020 Feb 12, 2021	BUY	$9.33 - $12.48 $42,096 - $56,309	4,512 Added 16.69%	31,545 $390,000
Q3 2020 Nov 12, 2020	SELL	$10.33 - $14.49 $16,961 - $23,792	-1,642 Reduced 5.73%	27,033 $289,000
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $144,486 - $191,894	12,575 Added 78.11%	28,675 $401,000
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $130,570 - $245,203	16,100 New	16,100 $185,000
Q2 2018 Aug 10, 2018	SELL	$13.44 - $17.59 $3.41 Million - $4.46 Million	-253,715 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$13.8 - $16.99 $3.5 Million - $4.31 Million	253,715 New	253,715 $4.23 Million

Others Institutions Holding INVA

# of Institutions

222

Shares Held

79.7M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.35B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Innoviva, Inc. Transaction History